IL115057A0 - Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use - Google Patents

Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use

Info

Publication number
IL115057A0
IL115057A0 IL11505795A IL11505795A IL115057A0 IL 115057 A0 IL115057 A0 IL 115057A0 IL 11505795 A IL11505795 A IL 11505795A IL 11505795 A IL11505795 A IL 11505795A IL 115057 A0 IL115057 A0 IL 115057A0
Authority
IL
Israel
Prior art keywords
antidote
employment
pharmaceutical
blood anticoagulants
anticoagulants
Prior art date
Application number
IL11505795A
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL115057A0 publication Critical patent/IL115057A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11505795A 1994-08-26 1995-08-24 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use IL115057A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430204A DE4430204A1 (en) 1994-08-26 1994-08-26 Medicament, which is suitable as an antidote for blood anticoagulants and its use

Publications (1)

Publication Number Publication Date
IL115057A0 true IL115057A0 (en) 1995-12-08

Family

ID=6526563

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11505795A IL115057A0 (en) 1994-08-26 1995-08-24 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use

Country Status (8)

Country Link
EP (1) EP0700682A3 (en)
JP (1) JP3838680B2 (en)
KR (1) KR960006920A (en)
AU (1) AU708409B2 (en)
CA (1) CA2156990A1 (en)
DE (1) DE4430204A1 (en)
IL (1) IL115057A0 (en)
ZA (1) ZA957140B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625642A1 (en) * 1996-06-26 1998-01-08 Max Planck Gesellschaft A process for preparing an antidote precursor for natural and synthetic thrombin inhibitors
KR20030031380A (en) * 2001-10-13 2003-04-21 이우진 Skateboard
WO2003099324A1 (en) * 2002-05-23 2003-12-04 Chugai Seiyaku Kabushiki Kaisha Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation
KR20040046045A (en) * 2002-11-26 2004-06-05 김재영 Paduk board and chess board that use copper material and maunfacturing method thereof
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
EP1874928A1 (en) 2005-04-13 2008-01-09 AstraZeneca AB A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
KR20130136988A (en) * 2010-10-06 2013-12-13 메디뮨 리미티드 Factor ii and fibrinogen for treatment of haemostatic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850202B2 (en) * 1977-11-10 1983-11-09 第一製薬株式会社 Production method of prothrompin
DE3043857A1 (en) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg METHOD FOR THE PRODUCTION OF BLOOD coagulation FACTORS AND THE PREPARATION OF FACTORS II AND VII THEREFORE PRODUCED
DD251078A1 (en) * 1986-07-17 1987-11-04 Bezirksinstitut Fuer Blutspend PROCESS FOR THE PREPARATION OF PROTHROMBIN CONCENTRATES
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
AU3098289A (en) 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
JPH0219400A (en) * 1988-07-07 1990-01-23 Green Cross Corp:The Production of thrombin or prothronbin
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
JP2549224B2 (en) * 1990-01-26 1996-10-30 イムノ・アクチェンゲゼルシャフト Recombinantly produced blood factor, method for expressing the blood factor, and vaccinia virus recombinant used in the method
DE4203965A1 (en) * 1992-02-11 1993-08-12 Max Planck Gesellschaft ANTIDOT FOR HIRUDIN AND SYNTHETIC THROMBIN INHIBITORS
AT397391B (en) * 1992-05-15 1994-03-25 Immuno Ag USE OF PROTHROMIN FRAGMENTS

Also Published As

Publication number Publication date
EP0700682A3 (en) 1996-05-29
JPH0859505A (en) 1996-03-05
KR960006920A (en) 1996-03-22
DE4430204A1 (en) 1996-02-29
JP3838680B2 (en) 2006-10-25
ZA957140B (en) 1996-03-26
AU3025695A (en) 1996-03-07
CA2156990A1 (en) 1996-02-27
EP0700682A2 (en) 1996-03-13
AU708409B2 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
EP0960628A4 (en) Syringe serving also as an ampule and syringe for collecting blood
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
BR9007323A (en) GORGE
GB2220143B (en) Single-use syringe
AU6048994A (en) Blood lancing device
PT934057E (en) MEDICAL FORMULATIONS OF AEROSOLS WITH FORMOTEROL
GB2213383B (en) Single-use syringe
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
IL93843A0 (en) Disposable syringe
IL115058A0 (en) Compositions which are suitable for employment as antidotes to blood anticoagulants and their use
AU6068290A (en) Invalid walker
GB9414143D0 (en) Improvements relating to blood sampling devices
ZA957140B (en) Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use
AU4967290A (en) Single-use syringe
EP0433250A3 (en) Disposable syringe
AU7737991A (en) Medical uses of m-csf
AU4821190A (en) Disposable hypodermic syringe
PL304799A1 (en) Disposable syringe
AU5223490A (en) Non reusable hypodermic syringe
AU593513B3 (en) Disposable hypodermic syringe
GB9413010D0 (en) Novel types of medical use for nystatin
TW320056U (en) Novel structure of safe syringe
GB8915253D0 (en) Medicament for application to damaged skin
AU3833289A (en) Single-use syringe
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II